PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
282 hedge funds and large institutions have $5.69B invested in PRA Health Sciences, Inc. in 2017 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 108 increasing their positions, 89 reducing their positions, and 39 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
56% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 39
21% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 89
19% more capital invested
Capital invested by funds: $4.78B → $5.69B (+$905M)
8% more funds holding
Funds holding: 261 → 282 (+21)
2% less call options, than puts
Call options by funds: $2.59M | Put options by funds: $2.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$70.4M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$49.9M |
| 3 |
Bank of New York Mellon
New York
|
+$49.3M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$42.1M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$36.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$64.2M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$55.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$48.9M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$35.3M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$32.1M |
PRAH Hedge Fund Activity: Q4 2017 in Review
282 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2017, worth a combined $5.69B — up 19% from $4.78B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new PRAH positions and 39 closed out — a net gain of 22 holders — while 108 added to existing stakes and 89 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $70.4M. The largest seller was Millennium Management, cutting an estimated $64.2M.
- 282 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2017, up from 261 in Q3 2017.
- Funds reported $5.69B of PRA Health Sciences, Inc. stock for Q4 2017, up 19% quarter-over-quarter.
- 61 funds opened new PRA Health Sciences, Inc. positions in Q4 2017 and 39 closed out, a net change of +22 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2017 was Capital Research Global Investors, an estimated $70.4M added.
- The largest PRA Health Sciences, Inc. seller in Q4 2017 was Millennium Management, an estimated $64.2M sold.
Based on aggregated 13F filings for Q4 2017.